TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans
Alzheimer's & Dementia · 2025-02 · 21 (2)
DOI: 10.1002/alz.14468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.12.2024. Verfasst von Ruben Riordan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Nerve Tissue Proteins, Membrane Proteins, Frontotemporal Lobar Degeneration, Neurodegenerative Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Veterans Affairs, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
INTRODUCTION Genetic variation in the lysosomal and transmembrane protein 106B (TMEM106B) modifies risk for several neurodegenerative disorders, especially frontotemporal lobar degeneration (FTLD). The C‐terminal (CT) domain of TMEM106B occurs as fibrillar protein deposits in the brains of dementia patients. METHODS To determine the TMEM CT aggregation propensity and neurodegenerative potential, we generated transgenic Caenorhabditis elegans expressing the human TMEM CT fragment aggregating in FTLD cases. RESULTS Pan‐neuronal expression of human TMEM CT in C. elegans causes severe neuronal dysfunction driving neurodegeneration. Cytosolic aggregation of TMEM CT proteins accompanied by behavioral dysfunction and neurodegeneration. Loss of pgrn‐1 did not modify TMEM CT phenotypes suggesting TMEM CT aggregation occurs downstream of PGRN loss of function. The mechanistic drivers of TMEM106B proteinopathy appear distinct from known modifiers of tauopathy. DISCUSSION Our data demonstrate that TMEM CT aggregation can kill neurons. TMEM106B transgenic C.elegans provide a useful model for characterizing TMEM106B proteinopathy‐mediated neurodegeneration in FTLD. Highlights Pan‐neuronal expression of human TMEM106B C‐terminal fragments (TMEM CT) in C. elegans neurons drives a suite of disease‐related phenotypes useful for modeling the molecular and cellular features of TMEM106B neuropathology. TMEM CT expression results in extensive TMEM aggregation and accumulation of highly detergent insoluble protein species. TMEM CT expression causes moderate to severe neuronal dysfunction dependent on TMEM CT abundance as measured by stereotypical behavioral readouts. TMEM CT expression drives significant neurodegenerative changes. Dendra2 tagged TMEM exhibits similar properties to untagged TMEM allowing ready visualization of the protein. TMEM CT aggregates accumulate adjacent to but not within lysosomes. PGRN loss of function does not impact TMEM CT toxicity. Modifiers of tau and TDP‐43 proteinopathies have little impact on TMEM CT‐related neurodegenerative phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
- Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
- Graduate Program in Neuroscience, University of Washington, Seattle, Washington, USA.
- Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Brian C Kraemer
Förderung
- U.S. Department of Veterans Affairs
- NIA NIH HHS
- NIH HHS
- NIDDK NIH HHS
- NINDS NIH HHS
- BLRD VA
- Geriatric Research Education and Clinical Center
- National Institutes of Health
Zitieren
APA
Riordan, R., Saxton, A., Han, M., McMillan, P. J., Kow, R. L., Liachko, N. F., & Kraemer, B. C. (2025). TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14468
Vancouver
Riordan R, Saxton A, Han M, McMillan PJ, Kow RL, Liachko NF, et al. TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14468
BibTeX
@article{Riordan2025,
author = {Riordan, Ruben and Saxton, Aleen and Han, Marina and McMillan, Pamela J and Kow, Rebecca L and Liachko, Nicole F and Kraemer, Brian C},
title = {TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {2},
doi = {10.1002/alz.14468}
}
EUVIMED